- January 19, 2016
Anecova world premiere: first commercialisation of its Natural Fertilisation procedure
- November 30, 2015
IVF revolution that signals end of the 'test tube' baby era...by allowing fertilisation to occur inside a woman's body
- November 28, 2015
Silicone implant in womb could boost IVF success
- September 11, 2015
The Anecova medical device has been approved in UK by the HFEA for the use in clinical practice in the treatment of infertility.
- July 30, 2015
Hsa-miR-30d, secreted by the human endometrium, is taken up by the pre-implantation embryo and might modify its transcriptome
Anecova is a Swiss life science company focused on creating innovative Assisted Reproductive Technologies (ART) with the goals of bringing fertility treatment as close as possible to the natural conception and improving the overall quality of fertility care.
Natural Development: A more physiological approach to ART treatments
AneVivo, our first product, restores fertilization to the natural environment of the maternal womb using an In Vivo procedure. This technology offers numerous benefits to both the mother and the embryos.
- The mother benefits psychologically by playing an active role in the fertilization of her embryos.
- It is expected that the presence of the embryos in the maternal environment will lead to the mother being better prepared for, and more receptive to, embryo implantation.
- The embryos benefit at the start of their life, during the fertilization and early development, from optimal conditions within the maternal environment. This is expected to optimize the production of highly competent embryos.